Lymphatic Anomalies Registry for the Assessment of Outcome Data

Lymphatic Malformation Clinical Trial

Official title: Lymphatic Anomalies Registry for the Assessment of Outcome Data

Status Recruiting

Clinical Trial Summary

Lymphatic anomalies are a rare subset of vascular anomalies that are poorly understood. the understanding of the natural history, long-term outcomes, risk factors for morbidity and mortality, and the relative benefit of medical therapies and procedures is limited.The goal of this project is to better understand these diseases and improve the care of theses rare patients. To do this, the investigators are conducting an observational study of patients with lymphatic anomalies, including an annual follow-up questionnaire to gather prospective data on mortality, morbidity, treatments, and functionality as well as quality of life.

Clinical Trial Description

The purpose of the Lymphatic Anomalies Registry, created at Boston Children's Hospital, is to create a database to help current and future patients diagnosed with a lymphatic anomaly. The ultimate goal of the registry is to better understand and predict responses to therapies and risk factors for complications. Although the Lymphatic Anomalies Registry exists at Boston Children's Hospital, patients can be entered into the registry regardless of whether or not they visit Boston Children's Hospital, thus increasing the program's accessibility. The Lymphatic Anomalies Registry includes patients who have vascular anomalies with a lymphatic component across various diagnoses. From the patient's perspective, participation in the Lymphatic Anomalies Registry means taking part in a short, thirty minute interview, and providing the registry with access to medical records. The interview is conducted verbally with study staff of the Lymphatic Anomalies Registry, and can take place either at the hospital, or over the phone. During the interview, the registry will inquire about the patient's diagnosis, disease features, medical therapies, and procedures. Interested prospective patients will receive an introductory packet from the registry with information on how to proceed in the registry process. All obtained patient information is housed on a secure, HIPPA compliant, internal database, managed by Boston Children's Hospital staff. Patient information entered into the external database is de-identified. The research teams will also obtain a medical record release form to request the patient's medical record for review in our study. ;

Related Conditions & MeSH terms

• Blue Rubber Bleb Nevus Syndrome
• Bone Diseases
• Central Conducting Lymphatic Anomaly
• CLOVES Syndrome
• Congenital Abnormalities
• Generalized Lymphatic Anomaly (GLA)
• Gorham-Stout Disease (Disappearing Bone Disease)
• Hemangioendothelioma
• Kaposiform Hemangioendothelioma/Tufted Angioma
• Kaposiform Lymphangiomatosis
• Klippel-Trenaunay Syndrome
• Lymphangioleiomyomatosis
• Lymphangioma
• Lymphangiomatosis
• Lymphatic Abnormalities
• Lymphatic Malformation
• Syndrome

• NCT number: NCT02399527
• Study type: Observational [Patient Registry]
• Source: Boston Children's Hospital
• Contact: Kelsey Deemer, BS
• Phone: 617-355-5226
• Email: Lymphaticregistry@childrens.harvard.edu
• Status: Recruiting
• Start date: June 2013
• Completion date: June 2035